CXCL10 and pulmonary fibrosis: Induced pluripotent stem cells (iPSCs) attenuate pulmonary fibrosis, neutrophil accumulation, and improve survival after bleomycin treatment by increasing antifibrotic Cxcl10 production in injured lungs [310].